Dr. János Filakovský has been appointed chief executive officer of TFS International, a mid-size CRO founded in 1996 in Sweden. Dr. Filakovský brings extensive experience in life sciences industry, including more than 20 years serving in various leadership roles at Quintiles.

Most recently he was Regional Business Unit Head overseeing operations, legal administration, finance, business strategy, as well as the growth of the Quintiles Clinical Operations business in Europe, Middle East and Africa, and managing director Eastern Europe Middle East Region.  

Dr. Filakovský said, “TFS is a great company with huge potential. This is a critical time for the Life Sciences Industry and for our company. TFS has enjoyed successful growth and we have the ability to do more. Rapidly evolving technology, scientific knowledge and digitalization of clinical research processes are reshaping the Life Sciences industry. We aim to strengthen and transform TFS for tomorrow.  We will help our customers develop better, safer treatments – in a faster and more efficient way.”

From his successor Jim Utterback, “János brings a perfect blend of Science, Medicine, Globality and Business and Operational acumen to TFS. I am very much looking forward to him joining in February to further accelerate our capabilities, service offerings and M&A strategy.”